ViiV HIV shot passes late-stage trials

ViiV Healthcare has announced that its once-a-month shot, designed as an alternative to daily doses of HIV treatment drugs, has met primary endpoints in a pair of pivotal phase III studies.

Source: PharmaManufacturing.com - March 8, 2019 Category: Pharmaceuticals Source Type: news